Israel Englander Relay Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,149,177 shares of RLAY stock, worth $7.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,149,177
Previous 227,906
404.23%
Holding current value
$7.18 Million
Previous $1.89 Million
296.19%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
179Shares Held
126MCall Options Held
16.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$174 Million1.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$73.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$65.9 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$52.8 Million4.75% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$39.9 Million0.7% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $751M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...